# US 2026/0038677 A1 · Neurostimulation parameter authentication and expiration system for neurostimulation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0038677 A1
- Document ID: US20260038677A1
- Status: Published application
- Kind: A1
- Application number: 19/356,022
- Filed: 2025-10-10
- Published: 2026-02-05
- Earliest claimed: 2021-05-17
- Assignees: SetPoint Medical Corporation
- Applicants: SetPoint Medical Corporation
- Inventors: Guillermo Alonso CALLE; Jacob Aaron JOHNSTON
- Web page: https://patentgrep.com/patent/US20260038677A1

## CPC

- G16H 40/40: for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
- G16H 40/63: for local operation
- A61N 1/0556: {Cuff electrodes}
- A61N 1/36053: {adapted for vagal stimulation (A61N1/36114 takes precedence)}
- A61N 1/37247: {User interfaces, e.g. input or presentation means}
- A61N 1/3787: {from an external energy source}
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
- G16H 40/67: for remote operation
- G16H 80/00: ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
- H04L 9/3247: {involving digital signatures}
- H04L 9/3268: {using certificate validation, registration, distribution or revocation, e.g. certificate revocation list [CRL]}
- H04L 63/0823: {using certificates (cryptographic mechanisms or cryptographic arrangements for entity authentication involving certificates H04L9/3263)}
- H04L 63/083: {using passwords (cryptographic mechanisms or cryptographic arrangements for entity authentication using a predetermined code H04L9/3226)}
- H04L 63/108: {when the policy decisions are valid for a limited amount of time}
- H04W 12/069: using certificates or pre-shared keys
- H04W 12/082: using revocation of authorisation
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- H04L: TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION (arrangements common to telegraphic and telephonic communication H04M)
- H04W: WIRELESS COMMUNICATION NETWORKS (broadcast communication H04H; communication systems using wireless links for non-selective communication, e.g. wireless extensions H04M1/72)

## Abstract

Methods and apparatuses (e.g., devices and systems) for securely accessing, activating and/or updating vagus nerve stimulators. In particular, described herein are methods and apparatuses for securing providing, verifying and/or executing digital prescriptions for implantable (including implanted) vagus nerve stimulation systems that may be used for treating inflammation. These methods and apparatuses (including software and/or firmware) may be adapted for used with low-energy requirements of the implanted components.

## Claims

### Claim 1

A method of setting parameters of an implanted therapy system, the method comprising:
receiving, in the implanted therapy system, a set of neural stimulation parameters from a user with a digitally signed certificate, wherein the digitally signed certificate was provided to the user by a remote server after verifying that the user is a clinician who has provided a recognized user name and password to the remote server;
verifying, by the implanted therapy system, that a digital signature on the digitally signed certificate corresponds to an authorized user by either:
(1) using a unique, implant-specific key to confirm the digital signature, wherein the implant-specific key is known only to the implanted therapy system and to the remote server, or
(2) using a public key maintained in the implanted therapy system to confirm the digital signature corresponds to a private key held by only the remote server; and
setting neural stimulation parameters of the implanted therapy system based on the set of neural stimulation parameters received from the authorized user.

### Claim 2 (depends on 1)

The method of claim 1, wherein the neural stimulation parameters affect a neural stimulation of a Cholinergic Anti-inflammatory Pathway (NCAP).

### Claim 3 (depends on 2)

The method of claim 2, wherein the neural stimulation of the Cholinergic Anti-inflammatory Pathway (NCAP) provides therapeutic intervention for inflammation-mediated diseases or disorders.

### Claim 4 (depends on 2)

The method of claim 2, wherein the neural stimulation of the Cholinergic Anti-inflammatory Pathway (NCAP) provides therapeutic intervention for rheumatologic diseases or disorders.

### Claim 5 (depends on 1)

The method of claim 1, wherein the neural stimulation parameters comprise an expiration date and/or time for the neural stimulation parameters.

### Claim 6 (depends on 5)

The method of claim 5, further comprising suspending neural stimulation by the implanted therapy system after the expiration date and/or time or after a specified number of stimulation treatments have been delivered as counted in a nonvolatile memory of the implanted therapy system.

### Claim 7 (depends on 5)

The method of claim 5, further comprising renewing the expiration date and/or time by receiving a second communication from the user that is verified by the implanted therapy system by verifying a digital signature on a second digitally signed certificate received with the second communication including the renewed expiration date and/or time.

### Claim 8 (depends on 1)

The method of claim 1, further comprising verifying a date and/or time of the implanted therapy system using a set of neural stimulation parameters from a second digitally signed certificate and verifying, by the implanted therapy system, that a digital signature on the second digitally signed certificate corresponds to an authorized user and setting neural stimulation parameters of the implanted therapy system based on the set of neural stimulation parameters received from the authorized user once the digital signature on the second digitally signed certificate is verified.

### Claim 9

A method of setting a date and/or time of an implanted therapy system, the method comprising:
receiving, in the implanted therapy system, a date and/or time setting for the implanted therapy system with a digitally signed certificate, wherein the digitally signed certificate was provided by a remote server;
verifying, by the implanted therapy system, that a digital signature on the digitally signed certificate corresponds to an authorized instruction by either:
(1) using a unique, implant-specific key to confirm the digital signature, wherein the implant-specific key is known only to the implanted therapy system and to the remote server, or
(2) using a public key maintained in the implanted therapy system to confirm the digital signature corresponds to a private key held by only the remote server; and
modifying the date and/or time setting of the implanted therapy system based on the received date and/or time setting once the digital signature is verified.

### Claim 10 (depends on 9)

The method of claim 9, further comprising modifying operation of the implanted therapy system based on a communication received from the authorized instruction.

### Claim 11 (depends on 10)

The method of claim 10, wherein modifying operation of the implanted therapy system comprises setting electrical stimulation parameters for the implantable therapy system.

### Claim 12 (depends on 11)

The method of claim 11, wherein the electrical stimulation parameters include an expiration date for the electrical stimulation parameters.

### Claim 13 (depends on 12)

The method of claim 12, further comprising suspending electrical stimulation by the implanted therapy system after the expiration date or after a specified number of stimulation treatments have been delivered as counted in a nonvolatile memory of the implanted therapy system.

### Claim 14 (depends on 12)

The method of claim 12, further comprising renewing the expiration date and/or time by receiving a second communication from a user that is verified by the implanted therapy system by verifying a digital signature on a second digitally signed certificate received with the second communication including the renewed expiration date and/or time.

### Claim 15 (depends on 9)

The method of claim 9, further comprising verifying a date and/or time of the implanted therapy system by receiving, in the implanted therapy system, a date and/or time setting for the implanted therapy system with a second digitally signed certificate, verifying that a digital signature on the second digitally signed certificate corresponds to an authorized date and/or time setting, and modifying the date and/or time setting of the implanted therapy system based on the received date and/or time setting once the digital signature on the second digitally signed certificate is verified.

### Claim 16

A method of updating software and/or firmware of an implanted therapy system, the method comprising:
receiving, in the implanted therapy system, a software and/or firmware update for the implanted therapy system with a digitally signed certificate, wherein the digitally signed certificate was provided by a remote server;
verifying, by the implanted therapy system, that a digital signature on the digitally signed certificate corresponds to an authorized instruction by either:
(1) using a unique, implant-specific key to confirm the digital signature, wherein the implant-specific key is known only to the implanted therapy system and to the remote server, or
(2) using a public key maintained in the implanted therapy system to confirm the digital signature corresponds to a private key held by only the remote server; and
updating the software and/or firmware of the implanted therapy system based on the received software and/or firmware update once the digital signature is verified.

### Claim 17 (depends on 16)

The method of claim 16, wherein updating the software and/or firmware of the implanted therapy system comprises updating or modifying an existing prescription.

### Claim 18 (depends on 16)

The method of claim 16, wherein updating the software and/or firmware of the implanted therapy system comprises adding or modifying electrical stimulation parameters for the implanted therapy system.

### Claim 19 (depends on 16)

The method of claim 16, wherein updating the software and/or firmware of the implanted therapy system comprises adding or modifying neural stimulation parameters for the implanted therapy system.

### Claim 20 (depends on 16)

The method of claim 16, further comprising verifying a date and/or time of the implanted therapy system by:
receiving, in the implanted therapy system, a software and/or firmware update for the implanted therapy system from a second digitally signed certificate;
verifying, by the implanted therapy system, that a digital signature on the second digitally signed certificate corresponds to an authorized user by either:
(1) using a unique, implant-specific key to confirm the digital signature, wherein the implant-specific key is known only to the implanted therapy system and to the remote server, or
(2) using a public key maintained in the implanted therapy system to confirm the digital signature corresponds to a private key held by only the remote server; and
updating the software and/or firmware of the implanted therapy system based on the received software and/or firmware update once the digital signature on the second digitally signed certificate is verified.
